Nuvalent Inc-a
(NUVL)
|
11.6 |
$522M |
|
20M |
26.09 |
Glaukos Corp Note 2.750% 6/1 (Principal)
|
7.5 |
$336M |
|
272M |
1.24 |
Neurocrine Biosciences
(NBIX)
|
3.9 |
$177M |
|
1.7M |
101.22 |
Catalyst Pharmaceutical Partners
(CPRX)
|
3.8 |
$172M |
|
10M |
16.58 |
Natera Note 2.250% 5/0 (Principal)
|
3.7 |
$164M |
|
101M |
1.62 |
Viatris
(VTRS)
|
3.6 |
$163M |
|
17M |
9.62 |
Adapthealth Corp Common Stock
(AHCO)
|
2.9 |
$132M |
|
11M |
12.43 |
Tabula Rasa Healthcare Note 1.750% 2/1 (Principal)
|
2.6 |
$117M |
|
145M |
0.81 |
Ionis Pharmaceuticals Note 4/0 (Principal)
|
2.6 |
$117M |
|
128M |
0.91 |
Amedisys
(AMED)
|
2.4 |
$109M |
|
1.5M |
73.55 |
Brookdale Sr Living Note 2.000%10/1 (Principal)
|
2.3 |
$105M |
|
146M |
0.72 |
Intercept Pharmaceuticals In Note 3.500% 2/1 (Principal)
|
2.3 |
$101M |
|
98M |
1.03 |
Accolade Note 0.500% 4/0 (Principal)
|
2.2 |
$97M |
|
123M |
0.79 |
Apellis Pharmaceuticals Note 3.500% 9/1 (Principal)
|
2.1 |
$96M |
|
52M |
1.85 |
Insmed Note 1.750% 1/1 (Principal)
|
2.1 |
$94M |
|
103M |
0.91 |
Deciphera Pharmaceuticals
|
1.8 |
$81M |
|
5.2M |
15.45 |
Larimar Therapeutics
(LRMR)
|
1.7 |
$77M |
|
17M |
4.53 |
Pacira Biosciences Note 0.750% 8/0 (Principal)
|
1.7 |
$75M |
|
82M |
0.92 |
Silverback Therapeutics
(SPRY)
|
1.6 |
$72M |
|
11M |
6.51 |
Centene Corporation
(CNC)
|
1.5 |
$68M |
|
1.1M |
63.21 |
Silk Road Medical Inc Common
|
1.5 |
$68M |
|
1.7M |
39.13 |
Guardant Health Note 11/1 (Principal)
|
1.3 |
$60M |
|
89M |
0.67 |
Amylyx Pharmaceuticals
(AMLX)
|
1.3 |
$58M |
|
2.0M |
29.34 |
Nanostring Technologies Note 2.625% 3/0 (Principal)
|
1.3 |
$58M |
|
70M |
0.83 |
Intercept Pharmaceuticals In Note 3.250% 7/0 (Principal)
|
1.3 |
$57M |
|
58M |
0.99 |
Owens & Minor
(OMI)
|
1.3 |
$56M |
|
3.9M |
14.55 |
Mirum Pharmaceuticals
(MIRM)
|
1.1 |
$49M |
|
2.0M |
24.02 |
Brookdale Senior Living
(BKD)
|
1.1 |
$48M |
|
16M |
2.95 |
Enhabit Ord
(EHAB)
|
1.1 |
$47M |
|
3.4M |
13.91 |
Hillevax
(HLVX)
|
1.0 |
$47M |
|
2.8M |
16.53 |
Livongo Health Note 0.875% 6/0 (Principal)
|
1.0 |
$44M |
|
50M |
0.89 |
Merus N V
(MRUS)
|
1.0 |
$44M |
|
2.4M |
18.40 |
Caremax Com Cl A
|
0.9 |
$42M |
|
16M |
2.67 |
Springworks Therapeutics
(SWTX)
|
0.9 |
$41M |
|
1.6M |
25.74 |
Intra Cellular Therapies
(ITCI)
|
0.9 |
$40M |
|
734k |
54.15 |
Iveric Bio
|
0.8 |
$37M |
|
1.5M |
24.33 |
Ptc Therapeutics Note 1.500% 9/1 (Principal)
|
0.8 |
$36M |
|
32M |
1.13 |
Newamsterdam Pharma Company Ordinary Shares
(NAMS)
|
0.7 |
$34M |
|
2.5M |
13.26 |
Cogent Biosciences
(COGT)
|
0.7 |
$32M |
|
3.0M |
10.79 |
Evolus
(EOLS)
|
0.7 |
$30M |
|
3.6M |
8.46 |
Kura Oncology
(KURA)
|
0.6 |
$29M |
|
2.4M |
12.23 |
Health Catalyst Note 2.500% 4/1 (Principal)
|
0.6 |
$27M |
|
30M |
0.91 |
Pulmonx Corp
(LUNG)
|
0.6 |
$27M |
|
2.4M |
11.18 |
Docgo
(DCGO)
|
0.6 |
$27M |
|
3.1M |
8.65 |
Edgewise Therapeutics
(EWTX)
|
0.6 |
$26M |
|
3.9M |
6.67 |
Bellus Health Com New
|
0.6 |
$26M |
|
3.6M |
7.20 |
Krystal Biotech
(KRYS)
|
0.6 |
$25M |
|
312k |
80.06 |
Terns Pharmaceuticals
(TERN)
|
0.5 |
$24M |
|
2.1M |
11.84 |
Ideaya Biosciences
(IDYA)
|
0.5 |
$24M |
|
1.7M |
13.73 |
BioCryst Pharmaceuticals
(BCRX)
|
0.5 |
$23M |
|
2.8M |
8.34 |
Genedx Holdings Corp Com Cl A
|
0.5 |
$21M |
|
57M |
0.36 |
Ventyx Biosciences
(VTYX)
|
0.5 |
$21M |
|
617k |
33.50 |
Vigil Neuroscience
(VIGL)
|
0.4 |
$20M |
|
2.1M |
9.79 |
Viking Therapeutics
(VKTX)
|
0.4 |
$19M |
|
1.1M |
16.65 |
Guardant Health
(GH)
|
0.4 |
$18M |
|
779k |
23.44 |
Revolution Medicines
(RVMD)
|
0.4 |
$18M |
|
830k |
21.66 |
Xeris Biopharma Holdings Note 5.000% 7/1 (Principal)
|
0.4 |
$17M |
|
18M |
0.96 |
Alphatec Hldgs Com New
(ATEC)
|
0.4 |
$16M |
|
1.0M |
15.60 |
Da32 Life Scnce Tec Acqstn C Class A Com
|
0.4 |
$16M |
|
1.6M |
10.12 |
Oak Str Health Note 3/1 (Principal)
|
0.3 |
$15M |
|
15M |
0.99 |
Tarsus Pharmaceuticals
(TARS)
|
0.3 |
$15M |
|
1.2M |
12.57 |
Invitae Corp Note 2.000% 9/0 (Principal)
|
0.3 |
$14M |
|
16M |
0.90 |
Denali Therapeutics
(DNLI)
|
0.3 |
$14M |
|
595k |
23.04 |
Anaptysbio Inc Common
(ANAB)
|
0.3 |
$13M |
|
613k |
21.76 |
Roivant Sciences SHS
(ROIV)
|
0.3 |
$13M |
|
1.8M |
7.38 |
Invitae
(NVTAQ)
|
0.3 |
$13M |
|
9.3M |
1.35 |
Mineralys Therapeutics
(MLYS)
|
0.3 |
$11M |
|
729k |
15.66 |
Insmed Com Par $.01
(INSM)
|
0.3 |
$11M |
|
659k |
17.05 |
Iovance Biotherapeutics
(IOVA)
|
0.2 |
$11M |
|
1.8M |
6.11 |
Vaxcyte
(PCVX)
|
0.2 |
$11M |
|
295k |
37.48 |
Prime Medicine
(PRME)
|
0.2 |
$11M |
|
885k |
12.30 |
Fusion Pharmaceuticals
|
0.2 |
$11M |
|
2.8M |
3.77 |
Vera Therapeutics Cl A
(VERA)
|
0.2 |
$10M |
|
1.3M |
7.76 |
Nuvation Bio Com Cl A
(NUVB)
|
0.2 |
$9.7M |
|
5.9M |
1.66 |
Structure Therapeutics Sponsored Ads
(GPCR)
|
0.2 |
$8.9M |
|
375k |
23.79 |
Singular Genomics Systems In
|
0.2 |
$7.8M |
|
6.5M |
1.21 |
Pacific Biosciences of California
(PACB)
|
0.2 |
$7.5M |
|
650k |
11.58 |
Bluebird Bio
(BLUE)
|
0.2 |
$6.9M |
|
2.2M |
3.18 |
Alector
(ALEC)
|
0.1 |
$6.5M |
|
1.1M |
6.19 |
Castle Biosciences
(CSTL)
|
0.1 |
$6.2M |
|
272k |
22.72 |
Neogenomics Note 1.250% 5/0 (Principal)
|
0.1 |
$6.0M |
|
6.5M |
0.93 |
Foghorn Therapeutics
(FHTX)
|
0.1 |
$4.8M |
|
778k |
6.20 |
Cabaletta Bio
(CABA)
|
0.1 |
$3.8M |
|
464k |
8.27 |
Nyxoah S A SHS
(NYXH)
|
0.1 |
$3.4M |
|
455k |
7.47 |
Abeona Therapeutics Com New
(ABEO)
|
0.1 |
$2.5M |
|
870k |
2.82 |
Oncology Institu
(TOI)
|
0.1 |
$2.3M |
|
3.4M |
0.68 |
Annexon
(ANNX)
|
0.1 |
$2.2M |
|
584k |
3.85 |
Acutus Medical
(AFIB)
|
0.0 |
$2.0M |
|
2.7M |
0.75 |
Rain Therapeutics
|
0.0 |
$2.0M |
|
227k |
8.74 |
Orchard Therapeutics Spon Ads New
|
0.0 |
$1.7M |
|
316k |
5.37 |
Roivant Sciences *w Exp 09/30/202
|
0.0 |
$1.5M |
|
1.0M |
1.46 |
Caremax *w Exp 06/08/202
(CMAXW)
|
0.0 |
$324k |
|
672k |
0.48 |
Medavail Holdings Ord
|
0.0 |
$240k |
|
837k |
0.29 |
Butterfly Network *w Exp 02/12/202
(BFLY.WS)
|
0.0 |
$195k |
|
733k |
0.27 |
Newamsterdam Pharma Company *w Exp 11/22/202
(NAMSW)
|
0.0 |
$171k |
|
93k |
1.84 |
The Oncology Institute *w Exp 11/15/202
(TOIIW)
|
0.0 |
$81k |
|
1.3M |
0.07 |
Quantum Si *w Exp 06/10/202
(QSIAW)
|
0.0 |
$50k |
|
333k |
0.15 |
Somalogic *w Exp 08/31/202
|
0.0 |
$36k |
|
120k |
0.30 |
Medtech Acquisition Corp *w Exp 12/22/202
|
0.0 |
$21k |
|
333k |
0.06 |
Nuvation Bio *w Exp 07/07/202
(NUVB.WS)
|
0.0 |
$20k |
|
167k |
0.12 |
Senior Connect Acquisitn Cor *w Exp 12/31/202
|
0.0 |
$20k |
|
500k |
0.04 |
Surrozen *w Exp 08/01/203
(SRZNW)
|
0.0 |
$17k |
|
167k |
0.10 |
Sientra
(SIENQ)
|
0.0 |
$15k |
|
10k |
1.54 |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202
|
0.0 |
$14k |
|
333k |
0.04 |
Eucrates Biomedical Acqu Cor Unit 10/23/2027
|
0.0 |
$10.000000 |
|
1.00 |
10.00 |
Medtech Acquisition Corp Unit 12/18/2025
|
0.0 |
$10.000000 |
|
1.00 |
10.00 |